Investigation of genetic susceptibility factors for human longevity - A targeted nonsynonymous SNP study

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 694, Issue 1-2, 2010, Pages 13-19

  Flachsbart, Friederike ^a   Franke, Andre ^a   Kleindorp, Rabea ^a   Caliebe, Amke ^a   Blanché, Hélène ^b   Schreiber, Stefan ^a   Nebel, Almut ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

Aging; Candidate genes; Case control association; Centenarians

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 6; GENE PRODUCT; INSULIN RECEPTOR; NACHT LEUCINE RICH REPEAT PROTEIN 1; PROTEIN PERP; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; GENE DUPLICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETICS; GENOTYPE; GERMANY; HUMAN; INTRACELLULAR SIGNALING; LONGEVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGEVITY; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 78649449914     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2010.08.006     Document Type: Article

References (70)

1. McGue M., Vaupel J.W., Holm N., Harvald B. Longevity is moderately heritable in a sample of Danish twins born 1870-1880. J. Gerontol. 1993, 48:B237-244.
2. Herskind A.M., McGue M., Holm N.V., Sorensen T.I., Harvald B., Vaupel J.W. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum. Genet. 1996, 97:319-323.
3. Perls T.T., Wilmoth J., Levenson R., Drinkwater M., Cohen M., Bogan H., Joyce E., Brewster S., Kunkel L., Puca A. Life-long sustained mortality advantage of siblings of centenarians. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8442-8447.
4. Skytthe A., Pedersen N.L., Kaprio J., Stazi M.A., Hjelmborg J.V., Iachine I., Vaupel J.W., Christensen K. Longevity studies in GenomEUtwin. Twin. Res. 2003, 6:448-454.
5. Hjelmborg J.v.B., Iachine I., Skytthe A., Vaupel J.W., McGue M., Koskenvuo M., Kaprio J., Pedersen N.L., Christensen K. Genetic influence on human lifespan and longevity. Hum. Genet. 2006, 119:312-321.
6. Schächter F., Faure-Delanef L., Guenot F., Rouger H., Froguel P., Lesueur-Ginot L., Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat. Genet. 1994, 6:29-32.
7. Perls T., Kunkel L.M., Puca A.A. The genetics of exceptional human longevity. J. Am. Geriatr. Soc. 2002, 50:359-368.
8. Kirkwood T.B., Austad S.N. Why do we age?. Nature 2000, 408:233-238.
9. Partridge L., Gems D. Mechanisms of ageing: public or private?. Nat. Rev. Genet. 2002, 3:165-175.
10. Smith E.D., Tsuchiya M., Fox L.A., Dang N., Hu D., Kerr E.O., Johnston E.D., Tchao B.N., Pak D.N., Welton K.L., Promislow D.E.L., Thomas J.H., Kaeberlein M., Kennedy B.K. Quantitative evidence for conserved longevity pathways between divergent eukaryotic species. Genome Res. 2008, 18:564-570.
11. Guarente L., Aging What makes us tick?. Science 1997, 275:943-944.
12. Kuningas M., Mooijaart S.P., van Heemst D., Zwaan B.J., Slagboom P.E., Westendorp R.G. Genes encoding longevity: from model organisms to humans. Aging Cell 2008, 7:270-280.
13. Rattan S.I. Theories of biological aging: genes, proteins, and free radicals. Free Radic. Res. 2006, 40:1230-1238.
14. Kenyon C, Chang J., Gensch E., Rudner A., Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366:461-464.
15. Mihaylova V.T., Borland C.Z., Manjarrez L., Stern M.J., Sun H. The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:7427-7432.
16. Hwangbo D.S., Gershman B., Tu M.P., Palmer M., Tatar M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 2004, 429:562-566.
17. Christensen K., Johnson T.E., Vaupel J.W. The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 2006, 7:436-448.
18. Anselmi C.V., Malovini A., Roncarati R., Novelli V., Villa F., Condorelli G., Bellazzi R., Puca A.A. Association of the FOXO3A Locus with Extreme Longevity in a Southern Italian Centenarian Study. Rejuvenation Res. 2009, 12:95-104.
19. Flachsbart F., Caliebe A., Kleindorp R., Blanche H., von Eller-Eberstein H., Nikolaus S., Schreiber S., Nebel A. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2700-2705.
20. Pawlikowska L., Hu D., Huntsman S., Sung A., Chu C., Chen J., Joyner A.H., Schork N.J., Hsueh W.-C., Reiner A.P., Psaty B.M., Atzmon G., Barzilai N., Cummings S.R., Browner W.S., Kwok P.-Y., Ziv E. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell 2009, 8:460-472.
21. Willcox B.J., Donlon T.A., He Q., Chen R., Grove J.S., Yano K., Masaki K.H., Willcox D.C., Rodriguez B., Curb J.D. FOXO3A genotype is strongly associated with human longevity. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13987-13992.
22. Clancy D.J., Gems D., Harshman L.G., Oldham S., Stocker H., Hafen E., Leevers S.J., Partridge L. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 2001, 292:104-106.
23. Tatar M, Kopelman A., Epstein D., Tu M.P., Yin C.M., Garofalo R.S. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 2001, 292:107-110.
24. Bluher M., Kahn B.B., Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003, 299:572-574.
25. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., Cervera P., Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187.
26. Gems D., McElwee J.J. Ageing: microarraying mortality. Nature 2003, 424:259-261.
27. White M.F. Insulin signaling in health and disease. Science 2003, 302:1710-1711.
28. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 2005, 120:449-460.
29. Nebel A., Flachsbart F., Till A., Caliebe A., Blanché H., Arlt A., Häsler R., Jacobs G., Kleindorp R., Franke A., Shen B., Nikolaus S., Krawczak M., Rosenstiel P., Schreiber S. A functional EXO1 promoter variant is associated with prolonged life expectancy in centenarians. Mech. Ageing Dev. 2009, 130:691-699.
30. Ramensky V., Bork P., Sunyaev S. Human non-synonymous SNPs: server and survey. Nucl. Acids Res. 2002, 30:3894-3900.
31. Nebel A., Croucher P.J., Stiegeler R., Nikolaus S., Krawczak M., Schreiber S. No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7906-7909.
32. Blanché H., Cabanne L., Sahbatou M., Thomas G. A study of French centenarians: are ACE and APOE associated with longevity?. C. R. Acad. Sci. III 2001, 324:129-135.
33. Geesaman B.J., Benson E., Brewster S.J., Kunkel L.M., Blanche H., Thomas G., Perls T.T., Daly M.J., Puca A.A. Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:14115-14120.
34. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., Albrecht M., Mayr G., De La Vega F.M., Briggs J., Gunther S., Prescott N.J., Onnie C.M., Hasler R., Sipos B., Folsch U.R., Lengauer T., Platzer M., Mathew C.G., Krawczak M., Schreiber S. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 2007, 39:207-211.
35. De la Vega F.M., Lazaruk K.D., Rhodes M.D., Wenz M.H. Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP Genotyping assays and the SNPlex genotyping system. Mutat. Res. 2005, 573:111-135.
36. Franke A., Wollstein A., Teuber M., Wittig M., Lu T., Hoffmann K., Nurnberg P., Krawczak M., Schreiber S., Hampe J. GENOMIZER: an integrated analysis system for genome-wide association data. Hum. Mutat. 2006, 27:583-588.
37. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
38. Dupont W.D., Plummer W.D. Power and sample size calculations for studies involving linear regression. Control. Clin. Trials 1998, 19:589-601.
39. Benjamini Y., Krieger A.M., Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika 2006, 93:491-507.
40. R Development Core Team, A language and environment for statistical computing, R Foundation for Statistical Computing, Vienna, Austria, ISBN 3-900051-07-0 (2008) URL http://www.r-project.org/.
41. Ihrie R.A., Reczek E., Horner J.S., Khachatrian L., Sage J., Jacks T., Attardi L.D. Perp is a mediator of p53-Dependent apoptosis in diverse cell types. Curr. Biol. 2003, 13:1985-1990.
42. Liu F., Lo C.F., Ning X., Kajkowski E.M., Jin M., Chiriac C., Gonzales C., Naureckiene S., Lock Y.-W., Pong K., Zaleska M.M., Jacobsen J.S., Silverman S., Ozenberger B.A. Expression of NALP1 in cerebellar granule neurons stimulates apoptosis. Cell. Signal. 2004, 16:1013-1021.
43. Rössig L., Haendeler J., Hermann C., Malchow P., Urbich C., Zeiher A.M., Dimmeler S. Nitric oxide down-regulates MKP-3 mRNA levels. J. Biol. Chem. 2000, 275:25502-25507.
44. Groom L.A., Sneddon A.A., Alessi D.R., Dowd S., Keyse S.M. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. Embo J. 1996, 15:3621-3632.
45. Seger R, Krebs E. The MAPK signaling cascade. FASEB J. 1995, 9:726-735.
46. Zeliadt N.A., Mauro L.J., Wattenberg E.V. Reciprocal regulation of extracellular signal regulated kinase 1/2 and mitogen activated protein kinase phosphatase-3. Toxicol. Appl. Pharmacol. 2008, 232:408-417.
47. Chan D.W., Liu V.W.S., Tsao G.S.W., Yao K.-M., Furukawa T., Chan K.K.L., Ngan H.Y.S. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 2008, 29:1742-1750.
48. Okudela K., Yazawa T., Woo T., Sakaeda M., Ishii J., Mitsui H., Shimoyamada H., Sato H., Tajiri M., Ogawa N., Masuda M., Takahashi T., Sugimura H., Kitamura H. Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis. Am. J. Pathol. 2009, 175:867-881.
49. Xu S., Furukawa T., Kanai N., Sunamura M., Horii A. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. J. Hum. Genet. 2005, 50:159-167.
50. Furukawa T., Sunamura M., Horii A. Molecular mechanisms of pancreatic carcinogenesis. Cancer Sci. 2006, 97:1-7.
51. Attardi L.D., Reczek E.E., Cosmas C., Demicco E.G., McCurrach M.E., Lowe S.W., Jacks T. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Gen. Dev. 2000, 14:704-718.
52. Davies L, Gray D., Spiller D., White M.R.H., Damato B., Grierson I., Paraoan L. P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma. J. Cell. Mol. Med. 2009, 13:1995-2007.
53. Hildebrandt T., Preiherr J., Tarbe N., Klostermann S., Van Muijen G.N., Weidle U.H. Identification of THW, a putative new tumor suppressor gene. Anticancer Res. 2000, 20:2801-2809.
54. Paraoan L, Gray D., Hiscott P., Ebrahimi B., Damato B., Grierson I. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. Exp. Eye Res. 2006, 83:911-919.
55. Chu Z.-L., Pio F., Xie Z., Welsh K., Krajewska M., Krajewski S., Godzik A., Reed J.C. A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J. Biol. Chem. 2001, 276:9239-9245.
56. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-[beta]. Mol. Cell 2002, 10:417-426.
57. Jin Y., Mailloux C.M., Gowan K., Riccardi S.L., LaBerge G., Bennett D.C., Fain P.R., Spritz R.A. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 2007, 356:1216-1225.
58. Flachsbart F., Caliebe A., Nothnagel M., Kleindorp R., Nikolaus S., Schreiber S., Nebel A. Depletion of potential A2M risk haplotype for Alzheimer's disease in long-lived individuals. Eur. J. Hum. Genet. 2009, 18:59-61.
59. Li Y., Wang W.J., Cao H., Lu J., Wu C., Hu F.Y., Guo J., Zhao L., Yang F., Zhang Y.X., Li W., Zheng G.Y., Cui H., Chen X., Zhu Z., He H., Dong B., Mo X., Zeng Y., Tian X.L. Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations. Hum. Mol. Genet. 2009, 18:4897-4904.
60. Flachsbart F., Croucher P.J., Nikolaus S., Hampe J., Cordes C., Schreiber S., Nebel A. Sirtuin 1 (SIRT1) sequence variation is not associated with exceptional human longevity. Exp. Gerontol. 2006, 41:98-102.
61. Lenski R.E., Ofria C., Pennock R.T., Adami C. The evolutionary origin of complex features. Nature 2003, 423:139-144.
62. Soyer O.S., Bonhoeffer S. Evolution of complexity in signaling pathways. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16337-16342.
63. Gu X. Evolution of duplicate genes versus genetic robustness against null mutations. Trends Genet. 2003, 19:354-356.
64. Partridge L., Gems D. Benchmarks for ageing studies. Nature 2007, 450:165-167.
65. Tan Q., Zhao J.H., Zhang D., Kruse T.A., Christensen K. Power for genetic association study of human longevity using the case-control design. Am. J. Epidemiol. 2008.
66. Franceschi C., Bezrukov V., Blanche H., Bolund L., Christensen K., de Benedictis G., Deiana L., Gonos E., Hervonen A., Yang H., Jeune B., Kirkwood T.B., Kristensen P., Leon A., Pelicci P.G., Peltonen L., Poulain M., Rea I.M., Remacle J., Robine J.M., Schreiber S., Sikora E., Slagboom P.E., Spazzafumo L., Stazi M.A., Toussaint O., Vaupel J.W. Genetics of healthy aging in Europe: the EU-integrated project GEHA (GEnetics of Healthy Aging). Ann. N.Y. Acad. Sci. 2007, 1100:21-45.
67. Caliebe A., Kleindorp R., Blanche H., Christiansen L., Puca A.A., Rea I.M., Slagboom E., Flachsbart F., Christensen K., Rimbach G., Schreiber S., Nebel A. No or only population-specific effect of PON1 on human longevity: a comprehensive meta-analysis. Ageing Res. Rev. 2010, 9:238-244.
68. De Benedictis G., Franceschi C. The unusual genetics of human longevity. Sci. Aging Knowledge Environ. 2006, pe20.
69. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007, 128:92-105.
70. Varcasia O., Garasto S., Rizza T., Andersen-Ranberg K., Jeune B., Bathum L., Andreev K., Tan Q., Yashin A.I., Bonafe M., Franceschi C., De Benedictis G. Replication studies in longevity: puzzling findings in Danish centenarians at the 3'APOB-VNTR locus. Ann. Hum. Genet. 2001, 65:371-376.